177 related articles for article (PubMed ID: 32711927)
1. Outcome of staged excision with pathologic margin control in high-risk basal cell carcinoma of the head region.
Kavoussi R; Kavoussi H; Ebrahimi A; Salari N; Madani SH
An Bras Dermatol; 2020; 95(5):583-588. PubMed ID: 32711927
[TBL] [Abstract][Full Text] [Related]
2. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
[TBL] [Abstract][Full Text] [Related]
3. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
5. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma skin cancer of the head and neck: surgical treatment.
Akcam TM; Gubisch W; Unlu H
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):455-71. PubMed ID: 23084298
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
9. Mohs micrographic surgery.
Hruza GJ
Otolaryngol Clin North Am; 1990 Oct; 23(5):845-64. PubMed ID: 2259505
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma.
Moyer JS; Rudy S; Boonstra PS; Kraft C; Chinn SB; Baker SR; Schwartz JL; Bichakjian CK; Fullen D; Durham AB; Lowe L; Johnson TM
JAMA Dermatol; 2017 Mar; 153(3):282-288. PubMed ID: 28002553
[TBL] [Abstract][Full Text] [Related]
12. Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region.
Durmus Ucar AN; Durmus Kocaaslan FN; Salman A; Demirkesen C; Erdem Bayram F; Bayramicli M
J Cutan Med Surg; 2019; 23(3):258-264. PubMed ID: 30556424
[TBL] [Abstract][Full Text] [Related]
13. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
14. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
15. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
16. [Why is it important to differentiate trichoblastic carcinomas (CT) from basal cell carcinomas (CBC). About 21 cases].
Thomas M; Bruant-Rodier C; Bodin F; Cribier B; Huther M; Dissaux C
Ann Chir Plast Esthet; 2017 Jun; 62(3):212-218. PubMed ID: 28385570
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of linear basal cell carcinoma.
Ward JM; Russell M
Cutis; 2019 Aug; 104(2):114-116. PubMed ID: 31603954
[TBL] [Abstract][Full Text] [Related]
18. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
[TBL] [Abstract][Full Text] [Related]
19. Clinical factors influencing periocular surgical defects after Mohs micrographic surgery.
Carter KD; Nerad JA; Whitaker DC
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):83-91. PubMed ID: 10189634
[TBL] [Abstract][Full Text] [Related]
20. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
